Envision Healthcare Corporation, through its subsidiaries, provides various healthcare services in the United States. The company operates through three reportable segments: Physician Services, Medical Transportation, and Ambulatory Services. Its physician-led services encompass providers at approximately 1,500 clinical departments at healthcare facilities in 45 states and the District of Columbia that include emergency department and hospitalist, anesthesiology, radiology/tele-radiology, and children's services. The company also offers ambulatory surgical centers (ASCs) services that provide surgical procedures across multiple specialties, including gastroenterology, ophthalmology, orthopedics, and others. It owns and operates 260 ASCs in 35 states and the District of Columbia. In addition, it provides surgery services, such as management, oversight, and surgeon staffing for trauma surgery services; offers direct patient care and care coordination by clinicians outside the acute care setting through physician-led post-acute care services; and operates office-based medical practices that primarily focus on women's health, as well as provides physician staffing and related management services. Further, it offers medical transportation services in 38 states and the District of Columbia. The company offers its clinical solutions for health systems, payors, providers, and patients. Envision Healthcare Corporation was founded in 1992 and is based in Nashville, Tennessee.
Johnson Fistel Investigates Envision Healthcare Corporation; Encourages Long-Term Investors to Contact the Firm SAN DIEGO, Nov. 1, 2017 /PRNewswire/ -- Johnson Fistel, LLP is investigating potential violations of the federal and state securities laws by Envision Healthcare Corporation (EVHC) ("Envision") and certain of its officers. Envision, provides various healthcare services in the United States. March 2, 2015 through July 21, 2017. According to the Complaint, throughout the Class Period, Envision made materially false and misleading statements, and failed to disclose material information, to investors. On July 24, 2017, The New York Times reported that hospitals associated with the Company's subsidiary, EmCare Holdings, Inc., were disproportionately likely to engage in "surprise billing," in which patients who sought treatment at in-network facilities were treated by out-of-network physicians and then billed at higher rates." data-reactid="12">Recently, a Securities Class Action Complaint was filed on behalf of those who purchased securities of Envision between March 2, 2015 through July 21, 2017. According to the Complaint, throughout the Class Period, Envision made materially false and misleading statements, and failed to disclose material information, to investors. On July 24, 2017, The New York Times reported that hospitals associated with the Company's subsidiary, EmCare Holdings, Inc., were disproportionately likely to engage in "surprise billing," in which patients who sought treatment at in-network facilities were treated by out-of-network physicians and then billed at higher rates.
